{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:14:35Z","timestamp":1780514075539,"version":"3.54.1"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI136102"],"award-info":[{"award-number":["R21AI136102"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007108","name":"George Washington University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00789","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T05:15:58Z","timestamp":1588050958000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Nanoparticle-Based Immunoengineered Approaches for Combating HIV"],"prefix":"10.3389","volume":"11","author":[{"given":"Allan","family":"Bowen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","article-title":"HIV reproducibly establishes a latent infection after acute infection of T cells in vitro","volume":"22","author":"Jordan","year":"2003","journal-title":"EMBO J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijpharm.2017.08.064","article-title":"Nanoprecipitation process: from encapsulation to drug delivery","volume":"532","author":"Martinez Rivas","year":"2017","journal-title":"Int J Pharm"},{"key":"B3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems\u2013a review","volume":"415","author":"Fredenberg","year":"2011","journal-title":"Int J Pharm"},{"key":"B4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0163-7258(94)90023-X","article-title":"Coley's toxins, tumor necrosis factor and cancer research: a historical perspective","volume":"64","author":"Wiemann","year":"1994","journal-title":"Pharmacol Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1021\/ar800035u","article-title":"Gold nanoparticles in biology: beyond toxicity to cellular imaging","volume":"41","author":"Murphy","year":"2008","journal-title":"Acc Chem Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","article-title":"Microglial cells: the main HIV-1 reservoir in the brain","volume":"9","author":"Wallet","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e01248-17","DOI":"10.1128\/JVI.01248-17","article-title":"HIV fusion in dendritic cells occurs mainly at the surface and is limited by low CD4 levels","volume":"91","author":"Chauveau","year":"2017","journal-title":"J Virol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nri1960","article-title":"Dendritic-cell interactions with HIV: infection and viral dissemination","volume":"6","author":"Wu","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1089\/108729103321619773","article-title":"Adherence to HAART regimens","volume":"17","author":"Chesney","year":"2003","journal-title":"Aids Patient Care St"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.jana.2006.11.012","article-title":"Long-Term suppression of HIV infection: benefits and limitations of current treatment options","volume":"18","author":"Sension","year":"2007","journal-title":"J Assoc Nurses AIDS Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s13181-013-0325-8","article-title":"A review of the toxicity of HIV medications","volume":"10","author":"Margolis","year":"2014","journal-title":"J Med Toxicol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1038\/s41467-018-06843-5","article-title":"A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation","volume":"9","author":"Reeves","year":"2018","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1126\/science.1165706","article-title":"The challenge of finding a cure for HIV infection","volume":"323","author":"Richman","year":"2009","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"a007096","DOI":"10.1101\/cshperspect.a007096","article-title":"HIV latency","volume":"1","author":"Siliciano","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/sj.emboj.7600900","article-title":"NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation","volume":"25","author":"Williams","year":"2006","journal-title":"EMBO J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev-med-092112-152941","article-title":"Understanding HIV latency: the road to an HIV cure","volume":"66","author":"Dahabieh","year":"2015","journal-title":"Annu Rev Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5Delta32\/Delta32 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cell.2015.03.037","article-title":"Immunoengineering: how nanotechnology can enhance cancer immunotherapy","volume":"161","author":"Goldberg","year":"2015","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1039\/c6ib00233a","article-title":"T cell immunoengineering with advanced biomaterials","volume":"9","author":"Delcassian","year":"2017","journal-title":"Integr Biol (Camb)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1506","DOI":"10.1002\/wnan.1506","article-title":"Immunoengineering with biomaterials for enhanced cancer immunotherapy","volume":"10","author":"Xie","year":"2018","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1002\/adma.201402996","article-title":"Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis","volume":"26","author":"Wang","year":"2014","journal-title":"Adv Mater"},{"key":"B23","doi-asserted-by":"publisher","first-page":"13193","DOI":"10.1038\/ncomms13193","article-title":"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy","volume":"7","author":"Chen","year":"2016","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s41467-018-03473-9","article-title":"Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer","volume":"9","author":"Nam","year":"2018","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1800678","DOI":"10.1002\/smll.201800678","article-title":"Photothermal therapy generates a thermal window of immunogenic cell death in neuroblastoma","volume":"14","author":"Sweeney","year":"2018","journal-title":"Small"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1039\/C8BM01553H","article-title":"Prussian blue nanoparticle-based antigenicity and adjuvanticity trigger robust antitumor immune responses against neuroblastoma","volume":"7","author":"Cano-Mejia","year":"2019","journal-title":"Biomater Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2217\/nnm.10.1","article-title":"Emerging nanotechnology approaches for HIV\/AIDS treatment and prevention","volume":"5","author":"Mamo","year":"2010","journal-title":"Nanomedicine (Lond)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1570163816666190620111652","article-title":"Nanoparticles and its implications in HIV\/AIDS therapy","volume":"16","author":"Victor","year":"2019","journal-title":"Curr Drug Discov Technol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejpb.2018.06.002","article-title":"Nanotechnology approaches to eradicating HIV reservoirs","volume":"138","author":"Cao","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"B30","volume-title":"Nanotechnologies \u2014 Vocabulary \u2014 Part 2: Nano-objects","year":"2015"},{"key":"B31","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/jps.21970","article-title":"Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery","volume":"99","author":"Rao","year":"2010","journal-title":"J Pharm Sci"},{"key":"B33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S2055-6640(20)30275-2","article-title":"Establishment of latent HIV-1 reservoirs: what do we really know?","volume":"5","author":"Vanhamel","year":"2019","journal-title":"J Virus Erad"},{"key":"B34","doi-asserted-by":"publisher","first-page":"9838","DOI":"10.1073\/pnas.88.21.9838","article-title":"Lymphoid organs function as major reservoirs for human immunodeficiency virus","volume":"88","author":"Pantaleo","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1158\/1535-7163.MCT-06-0141","article-title":"Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery","volume":"5","author":"Sinha","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nano.2005.12.003","article-title":"Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles","volume":"2","author":"Reis","year":"2006","journal-title":"Nanomedicine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1080\/17425247.2017.1288212","article-title":"Long-acting slow effective release antiretroviral therapy","volume":"14","author":"Edagwa","year":"2017","journal-title":"Expert Opin Drug Deliv"},{"key":"B38","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1172\/JCI90025","article-title":"Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs","volume":"127","author":"Gnanadhas","year":"2017","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","first-page":"119476","DOI":"10.1016\/j.biomaterials.2019.119476","article-title":"A long acting nanoformulated lamivudine ProTide","volume":"223","author":"Smith","year":"2019","journal-title":"Biomaterials"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1097\/QAI.0000000000001170","article-title":"Creation of a long-acting nanoformulated 2',3'-dideoxy-3'-thiacytidine","volume":"74","author":"Guo","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1097\/QAD.0000000000000421","article-title":"Long-acting three-drug combination anti-HIV nanoparticles enhance drug exposure in primate plasma and cells within lymph nodes and blood","volume":"28","author":"Freeling","year":"2014","journal-title":"Aids"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s11095-017-2255-7","article-title":"Pharmacokinetic and tissue distribution profile of long acting tenofovir alafenamide and elvitegravir loaded nanoparticles in humanized mice model","volume":"34","author":"Prathipati","year":"2017","journal-title":"Pharm Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11095-016-2048-4","article-title":"Triple drug combination of zidovudine, efavirenz and lamivudine loaded lactoferrin nanoparticles: an effective nano first-line regimen for HIV therapy","volume":"34","author":"Kumar","year":"2017","journal-title":"Pharm Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"eaav6322","DOI":"10.1126\/sciadv.aav6322","article-title":"Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4+ T cell activation and HIV-1 latency reversal","volume":"5","author":"Cao","year":"2019","journal-title":"Sci Adv"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e34655","DOI":"10.7554\/eLife.34655","article-title":"Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells","volume":"7","author":"Battivelli","year":"2018","journal-title":"Elife"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2147\/IJN.S76517","article-title":"Sustained-release nanoART formulation for the treatment of neuroAIDS","volume":"10","author":"Jayant","year":"2015","journal-title":"Int J Nanomed"},{"key":"B47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s11671-015-1112-z","article-title":"PLGA-PEG nanoparticles coated with anti-CD45RO and loaded with HDAC plus protease inhibitors activate latent HIV and inhibit viral spread","volume":"10","author":"Tang","year":"2015","journal-title":"Nanoscale Res Lett"},{"key":"B48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.imlet.2017.05.002","article-title":"Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: a preliminary study","volume":"187","author":"Rostami","year":"2017","journal-title":"Immunol Lett"},{"key":"B49","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1126\/science.aat9120","article-title":"Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers","volume":"363","author":"Tokatlian","year":"2019","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.2174\/092986707781368513","article-title":"Nanochemistry-based immunotherapy for HIV-1","volume":"14","author":"Lori","year":"2007","journal-title":"Curr Med Chem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1126\/science.aad9195","article-title":"HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen","volume":"351","author":"Jardine","year":"2016","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.immuni.2017.04.021","article-title":"Particulate array of well-ordered HIV clade C env trimers elicits neutralizing antibodies that display a unique V2 cap approach","volume":"46","author":"Martinez-Murillo","year":"2017","journal-title":"Immunity"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1038\/s41467-019-10262-5","article-title":"Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence","volume":"10","author":"Sliepen","year":"2019","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1038\/s41467-019-12080-1","article-title":"Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle","volume":"10","author":"Brouwer","year":"2019","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.immuni.2019.10.008","article-title":"Vaccination with glycan-modified HIV NFL envelope trimer-liposomes elicits broadly neutralizing antibodies to multiple sites of vulnerability","volume":"51","author":"Dubrovskaya","year":"2019","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","first-page":"12041","DOI":"10.1038\/ncomms12041","article-title":"Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles","volume":"7","author":"He","year":"2016","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-3155-8-1","article-title":"Mode of antiviral action of silver nanoparticles against HIV-1","volume":"8","author":"Lara","year":"2010","journal-title":"J Nanobiotechnology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1021\/acs.langmuir.6b04295","article-title":"Hydrophobic nanoparticles reduce the \u03b2-sheet content of SEVI amyloid fibrils and inhibit SEVI-enhanced HIV infectivity","volume":"33","author":"Sheik","year":"2017","journal-title":"Langmuir"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e1802233","DOI":"10.1002\/adma.201802233","article-title":"T-cell-mimicking nanoparticles can neutralize HIV infectivity","volume":"30","author":"Wei","year":"2018","journal-title":"Adv Mater"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5656","DOI":"10.1038\/s41467-019-13468-9","article-title":"Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues","volume":"10","author":"Nahui Palomino","year":"2019","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/QAI.0000000000002233","article-title":"Semen extracellular vesicles from HIV-1-infected individuals inhibit HIV-1 replication in vitro, and extracellular vesicles carry antiretroviral drugs in vivo","volume":"83","author":"Welch","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s41563-019-0385-5","article-title":"Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations","volume":"18","author":"Shahbazi","year":"2019","journal-title":"Nat Mater"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/s41467-019-10366-y","article-title":"Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice","volume":"10","author":"Dash","year":"2019","journal-title":"Nat Commun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s12274-020-2684-1","article-title":"PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function","volume":"13","author":"Sweeney","year":"2020","journal-title":"Nano Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biomaterials.2016.11.048","article-title":"Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells","volume":"117","author":"Jones","year":"2017","journal-title":"Biomaterials"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.4049\/jimmunol.1700972","article-title":"Innate immune activation by cGMP-AMP nanoparticles leads to potent and long-acting antiretroviral response against HIV-1","volume":"199","author":"Aroh","year":"2017","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/acs.bioconjchem.8b00448","article-title":"Graphene quantum dots based systems as HIV inhibitors","volume":"29","author":"Iannazzo","year":"2018","journal-title":"Bioconjugate Chem"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41598-017-16703-9","article-title":"Characterization of nanodiamond-based anti-HIV drug delivery to the brain","volume":"8","author":"Roy","year":"2018","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.4155\/fmc.15.57","article-title":"Gold nanoparticles to improve HIV drug delivery","volume":"7","author":"Garrido","year":"2015","journal-title":"Future Med Chem"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e01475-16","DOI":"10.1128\/AAC.01475-16","article-title":"An enhanced emtricitabine-loaded long-acting nanoformulation for prevention or treatment of HIV infection","volume":"61","author":"Mandal","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1128\/AAC.00450-16","article-title":"Topical tenofovir disoproxil fumarate nanoparticles prevent HIV-1 vaginal transmission in a humanized mouse model","volume":"60","author":"Destache","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B72","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/polym9090423","article-title":"Cellulose acetate phthalate and antiretroviral nanoparticle fabrications for HIV pre-exposure prophylaxis","volume":"9","author":"Mandal","year":"2017","journal-title":"Polymers-Basel"},{"key":"B73","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/487439a","article-title":"HIV: shock and kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-med-052716-031710","article-title":"Novel latency reversal agents for HIV-1 cure","volume":"69","author":"Spivak","year":"2018","journal-title":"Annu Rev Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1073\/pnas.90.10.4674","article-title":"Go-6976, a selective inhibitor of protein-kinase-C, is a potent antagonist of human immunodeficiency virus-1 induction from latent low-level-producing reservoir cells-in vitro","volume":"90","author":"Qatsha","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e18270","DOI":"10.1371\/journal.pone.0018270","article-title":"Activation of latent HIV using drug-loaded nanoparticles","volume":"6","author":"Kovochich","year":"2011","journal-title":"PLoS ONE"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the step study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"B78","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF00328978","article-title":"The ideal vaccine","volume":"7","author":"Ada","year":"1991","journal-title":"World J Microb Biot"},{"key":"B80","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ymeth.2013.04.014","article-title":"Nanovaccines and their mode of action","volume":"60","author":"Zaman","year":"2013","journal-title":"Methods"},{"key":"B81","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.csbj.2015.11.001","article-title":"Self-assembling protein nanoparticles in the design of vaccines","volume":"14","author":"Lopez-Sagaseta","year":"2016","journal-title":"Comput Struct Biotec"},{"key":"B82","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","article-title":"Vaccination with recombinant fusion proteins incorporating toll-like receptor ligands induces rapid cellular and humoral immunity","volume":"25","author":"Huleatt","year":"2007","journal-title":"Vaccine"},{"key":"B83","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/QAI.0b013e3182a99590","article-title":"Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial","volume":"64","author":"Rodriguez","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B84","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12977-018-0432-3","article-title":"Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity","volume":"15","author":"Ren","year":"2018","journal-title":"Retrovirology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1128\/JVI.01366-08","article-title":"The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection","volume":"83","author":"Roan","year":"2009","journal-title":"J Virol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1021\/ac2030859","article-title":"Enzyme-linked immunosorbent assay-based method to quantify the association of small molecules with aggregated amyloid peptides","volume":"84","author":"Capule","year":"2012","journal-title":"Anal Chem"},{"key":"B87","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/mabi.200400189","article-title":"Conformational changes of the amyloid \u03b2-peptide (1-40) adsorbed on solid surfaces","volume":"5","author":"Giacomelli","year":"2005","journal-title":"Macromol Biosci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e25954","DOI":"10.1371\/journal.pone.0025954","article-title":"Effect of surfaces on amyloid fibril formation","volume":"6","author":"Moores","year":"2011","journal-title":"PLoS ONE"},{"key":"B89","doi-asserted-by":"publisher","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B90","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nrmicro3503","article-title":"HIV-1 capsid: the multifaceted key player in HIV-1 infection","volume":"13","author":"Campbell","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Yanez-Mo","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"B92","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1111\/febs.13110","article-title":"Genome modification by CRISPR\/Cas9","volume":"281","author":"Ma","year":"2014","journal-title":"FEBS J"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1099\/vir.0.000139","article-title":"Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR\/Cas9","volume":"96","author":"Li","year":"2015","journal-title":"J Gen Virol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.ymthe.2017.04.027","article-title":"CRISPR\/Cas9-mediated CCR5 ablation in human hematopoietic stem\/progenitor cells confers HIV-1 resistance in vivo","volume":"25","author":"Xu","year":"2017","journal-title":"Mol Ther"},{"key":"B96","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41551-018-0252-8","article-title":"Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours","volume":"2","author":"Lee","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"B97","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/v2020574","article-title":"CCR5: from natural resistance to a new anti-HIV strategy","volume":"2","author":"Lopalco","year":"2010","journal-title":"Viruses"},{"key":"B98","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2217\/imt.13.23","article-title":"T-cell therapies for HIV","volume":"5","author":"Lam","year":"2013","journal-title":"Immunotherapy"},{"key":"B99","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jcyt.2016.04.007","article-title":"T-cell therapies for HIV: preclinical successes and current clinical strategies","volume":"18","author":"Patel","year":"2016","journal-title":"Cytotherapy"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.ymthe.2018.08.015","article-title":"HIV-Specific, ex vivo expanded T cell therapy: feasibility, safety, and efficacy in ART-suppressed HIV-infected individuals","volume":"26","author":"Sung","year":"2018","journal-title":"Mol Ther"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/ni.1941","article-title":"The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1","volume":"11","author":"Yan","year":"2010","journal-title":"Nat Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1126\/science.1240933","article-title":"Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses","volume":"341","author":"Gao","year":"2013","journal-title":"Science"},{"key":"B103","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/wnan.78","article-title":"Quantum dots and nanocomposites","volume":"2","author":"Mansur","year":"2010","journal-title":"Wires Nanomed Nanobi"},{"key":"B104","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.2147\/IJN.S138624","article-title":"Quantum dots in imaging, drug delivery and sensor applications","volume":"12","author":"Matea","year":"2017","journal-title":"Int J Nanomed"},{"key":"B105","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s13365-014-0269-z","article-title":"Translational challenges in targeting latent HIV infection and the CNS reservoir problem","volume":"21","author":"Garrido","year":"2015","journal-title":"J Neurovirol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"151ra125","DOI":"10.1126\/scitranslmed.3004006","article-title":"Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men","volume":"4","author":"Anderson","year":"2012","journal-title":"Sci Trans Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1128\/AAC.02058-13","article-title":"Population pharmacokinetics of emtricitabine in HIV-1-infected adult patients","volume":"58","author":"Valade","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00789\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T10:44:58Z","timestamp":1615459498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00789\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":107,"alternative-id":["10.3389\/fimmu.2020.00789"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00789","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"article-number":"789"}}